Sera Prognostics (SERA) Research & Development (2020 - 2026)
Sera Prognostics posted quarterly Research & Development of $3.0 million for Q1 2026, down 9.12% year-on-year from $3.3 million in Q1 2025, and down 5.78% on a QoQ basis from $3.2 million in Q4 2025.
Sera Prognostics (SERA) has 7 years of Research & Development data on file, last reported at $3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 9.12% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $12.9 million (down 10.53% YoY), and the FY2025 full-year result was $13.2 million, down 10.58% from the prior year.
- Research & Development for Q1 2026 stood at $3.0 million, down from $3.2 million in the prior quarter.
- Across five years, Research & Development topped out at $4.4 million in Q2 2024 and bottomed at $3.0 million in Q1 2026.
- The 5-year median for Research & Development is $3.5 million (2022), against an average of $3.6 million.
- The widest annual swing landed in 2022, when Research & Development soared 53.3%; it then slipped 24.26% in 2025.
- A 5-year view of Research & Development shows it stood at $3.5 million in 2022, then increased by 11.76% to $3.9 million in 2023, then declined by 19.41% to $3.1 million in 2024, then rose by 2.45% to $3.2 million in 2025, then retreated by 5.78% to $3.0 million in 2026.
- The last three Research & Development figures came in at $3.0 million (Q1 2026), $3.2 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 | 3.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.03 Mn |
| Dec 31, 2025 | 3.22 Mn |
| Sep 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Jun 30, 2024 | 4.41 Mn |
| Mar 31, 2024 | 3.68 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 3.54 Mn |
| Jun 30, 2023 | 3.69 Mn |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 3.49 Mn |
| Sep 30, 2022 | 4.18 Mn |
| Jun 30, 2022 | 3.26 Mn |
| Mar 31, 2022 | 3.32 Mn |
| Dec 31, 2021 | 3.08 Mn |
| Sep 30, 2021 | 2.72 Mn |
| Jun 30, 2021 | 2.82 Mn |
| Mar 31, 2021 | 2.40 Mn |
| Dec 31, 2020 | 2.09 Mn |
| Sep 30, 2020 | 1.89 Mn |
| Jun 30, 2020 | 1.75 Mn |